135 related articles for article (PubMed ID: 34500126)
1. Graft-Versus-Host Disease Prophylaxis Using Low-Dose Antithymocyte Globulin in Peripheral Blood Stem Cell Transplantation-A Matched-Pair Analysis.
Shiratori S; Kurata M; Sugita J; Ota S; Kasahara S; Ishikawa J; Imada K; Onishi Y; Ishiyama K; Ashida T; Kanda Y; Ichinohe T; Fukuda T; Atsuta Y; Teshima T
Transplant Cell Ther; 2021 Dec; 27(12):995.e1-995.e6. PubMed ID: 34500126
[TBL] [Abstract][Full Text] [Related]
2. Clinical Benefit of Low-Dose Antithymocyte Globulin-Thymoglobulin as Graft-versus-Host Disease Prophylaxis in Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation from HLA-Identical Donors.
Takeuchi Y; Miyao K; Negishi S; Ohara F; Motegi K; Wakabayashi H; Yokota H; Kuwano S; Sawa H; Inagaki Y; Sawa M
Transplant Cell Ther; 2023 May; 29(5):325.e1-325.e10. PubMed ID: 36736783
[TBL] [Abstract][Full Text] [Related]
3. Antithymocyte Globulin Potentially Could Overcome an Adverse Effect of Acute Graft-versus-Host Disease in Matched-Related Peripheral Blood Stem Cell Transplantation.
Miyao K; Kuwatsuka Y; Murata M; Nagafuji K; Teshima T; Takeuchi Y; Shiratori S; Najima Y; Uchida N; Tanaka M; Sawa M; Ota S; Fukuda T; Ozawa Y; Kako S; Kawakita T; Ara T; Tanaka J; Kanda Y; Atsuta Y; Kanda J; Terakura S;
Transplant Cell Ther; 2022 Mar; 28(3):153.e1-153.e11. PubMed ID: 34954151
[TBL] [Abstract][Full Text] [Related]
4. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
[TBL] [Abstract][Full Text] [Related]
5. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
[TBL] [Abstract][Full Text] [Related]
6. [Antithymocyte globulin for GVHD prophylaxis in allogeneic hematopoietic stem cell transplantation].
Shiratori S
Rinsho Ketsueki; 2021; 62(8):1265-1274. PubMed ID: 34497215
[TBL] [Abstract][Full Text] [Related]
7. Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing 10/10 HLA-matched unrelated donor peripheral blood stem cell transplants: a multicentre, randomized controlled trial.
Zu Y; Li Z; Gui R; Liu Y; Zhang Y; Yu F; Zhao H; Fu Y; Zhan X; Wang Z; Xing P; Wang X; Wang H; Zhou J; Song Y
Bone Marrow Transplant; 2022 Oct; 57(10):1573-1580. PubMed ID: 35840747
[TBL] [Abstract][Full Text] [Related]
8. Role of antithymocyte globulin in matched sibling donor peripheral blood stem cell transplantation for hematologic malignancies.
Dou L; Wang L; Li X; Liu Y; Li F; Wang L; Gao X; Huang W; Wang S; Gao C; Yu L; Liu D
Medicine (Baltimore); 2021 Feb; 100(8):e24725. PubMed ID: 33663084
[TBL] [Abstract][Full Text] [Related]
9. Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donors.
Shiratori S; Sugita J; Fuji S; Aoki J; Sawa M; Ozawa Y; Hashimoto D; Matsuoka KI; Imada K; Doki N; Ashida T; Ueda Y; Tanaka M; Sawayama Y; Ichinohe T; Terakura S; Morishima S; Atsuta Y; Fukuda T; Teshima T
Bone Marrow Transplant; 2021 Sep; 56(9):2231-2240. PubMed ID: 33963304
[TBL] [Abstract][Full Text] [Related]
10. Low-dose antithymocyte globulin plus low-dose posttransplant cyclophosphamide combined with cyclosporine and mycophenolate mofetil for prevention of graft-versus-host disease after HLA-matched unrelated donor peripheral blood stem cell transplantation.
Sun X; Yang J; Cai Y; Wan L; Huang C; Qiu H; Tong Y; Xu X; Zhou K; Ding X; Song X
Bone Marrow Transplant; 2021 Oct; 56(10):2423-2431. PubMed ID: 34035462
[TBL] [Abstract][Full Text] [Related]
11. Optimal dose of rabbit thymoglobulin in conditioning regimens for unmanipulated, haploidentical, hematopoietic stem cell transplantation: Long-term outcomes of a prospective randomized trial.
Chang YJ; Wang Y; Mo XD; Zhang XH; Xu LP; Yan CH; Chen H; Chen YH; Chen Y; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
Cancer; 2017 Aug; 123(15):2881-2892. PubMed ID: 28301690
[TBL] [Abstract][Full Text] [Related]
12. [Application of low-dose ATG for GVHD prophylaxis in patients undergoing PBSCT aged over forty years old].
Liang C; Jiang EL; Yao JF; Ma QL; Zhai WH; Pang AM; Huang Y; Wei JL; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2018 Apr; 39(4):292-298. PubMed ID: 29779324
[No Abstract] [Full Text] [Related]
13. Anti-thymocyte globulin improves survival free from relapse and graft-versus-host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia-negative acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the EBMT.
Czerw T; Labopin M; Giebel S; Socié G; Volin L; Fegueux N; Masszi T; Blaise D; Chaganti S; Cornelissen JJ; Passweg J; Maertens J; Itälä-Remes M; Wu D; Mohty M; Nagler A
Cancer; 2018 Jun; 124(12):2523-2533. PubMed ID: 29603136
[TBL] [Abstract][Full Text] [Related]
14. Low-dose anti-thymocyte globulin for GVHD prophylaxis in HLA-matched allogeneic peripheral blood stem cell transplantation.
Shiratori S; Sugita J; Ota S; Kasahara S; Ishikawa J; Tachibana T; Hayashi Y; Yoshimoto G; Eto T; Iwasaki H; Harada M; Matsuo K; Teshima T;
Bone Marrow Transplant; 2021 Jan; 56(1):129-136. PubMed ID: 32624582
[TBL] [Abstract][Full Text] [Related]
15. High Risk of Recurrence of Malignancy Noted in Four-day rATG Regimen After Allogeneic PBSCT From Matched Sibling Donors.
Wang N; Wang H; Fang S; Du J; Huang S; Li F; Jin X; Jia M; Xu L; Dou L; Liu D
Transplant Cell Ther; 2022 Nov; 28(11):769.e1-769.e9. PubMed ID: 35973670
[TBL] [Abstract][Full Text] [Related]
16. Optimal Active Anti-Thymocyte Globulin Exposure Associated with Minimum Risk of Virus Reactivation and Comparable Acute Graft-Versus-Host Disease Under Adult Myeloablative Haploidentical Peripheral Blood Stem Cell Transplantation.
Wang H; Zhao Y; Fang S; Wang L; Peng B; Yang J; Wang N; Du J; Li F; Jin X; Luan S; Wu X; Dou L; Liu D
Transplant Cell Ther; 2022 Jun; 28(6):332.e1-332.e10. PubMed ID: 35314377
[TBL] [Abstract][Full Text] [Related]
17. High lymphocyte counts before antithymocyte globulin administration predict acute graft-versus-host disease.
Shiratori S; Ohigashi H; Ara T; Yasumoto A; Goto H; Nakagawa M; Sugita J; Onozawa M; Kahata K; Endo T; Hashimoto D; Teshima T
Ann Hematol; 2021 May; 100(5):1321-1328. PubMed ID: 33215225
[TBL] [Abstract][Full Text] [Related]
18. Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis.
Russell JA; Turner AR; Larratt L; Chaudhry A; Morris D; Brown C; Quinlan D; Stewart D
Biol Blood Marrow Transplant; 2007 Mar; 13(3):299-306. PubMed ID: 17317583
[TBL] [Abstract][Full Text] [Related]
19. Post-Transplant Cyclophosphamide and Thymoglobulin, a Graft-Versus-Host Disease Prophylaxis in Matched Sibling Donor Peripheral Blood Stem Cell Transplantations.
Kunacheewa C; Owattanapanish W; Jirabanditsakul C; Issaragrisil S
Cell Transplant; 2020; 29():963689720965900. PubMed ID: 33035116
[TBL] [Abstract][Full Text] [Related]
20. Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Ravinet A; Cabrespine A; Socié G; Milpied N; Yakoub Agha I; Nguyen S; Michallet M; Menard AL; Maillard N; Mohty M; Suarez F; Huynh A; Marchand T; Deteix C; Cassuto JP; Maury S; Chevallier P; Reman O; Peffault de Latour R; Bay JO
Transplantation; 2016 Aug; 100(8):1732-9. PubMed ID: 26528768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
